Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

✍ Scribed by Rajesh Krishna; Matt S Anderson; Arthur J Bergman; Bo Jin; Marissa Fallon; Josee Cote; Kim Rosko; Cynthia Chavez-Eng; Ryan Lutz; Daniel M Bloomfield; Maria Gutierrez; James Doherty; Fredrick Bieberdorf; Jeffrey Chodakewitz; Keith M Gottesdiener; John A Wagner

• Book ID: 117302178
• Publisher: The Lancet
• Year: 2007
• Tongue: English
• Weight: 200 KB
• Volume: 370
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(07)61813-3